Year in review 2008: Critical Care - sepsis

Critical Care

Volumn 13, Issue 5, 2009, Pages

  Opal, Steven M ^a   LaRosa, Steven P ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BIM PROTEIN; BIOLOGICAL MARKER; BLEOMYCIN; COPEPTIN; CORTICOTROPIN; DANAPAROID; ENDOTHELIN 1; GELATIN; GELSOLIN; HETASTARCH; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOLECULAR WEIGHT HYALURONAN; HYALURONIC ACID; HYDROCORTISONE; KERBS VON LUNGREN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLACEBO; PROTEIN BID; PROTEIN DISULFIDE ISOMERASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SOLUBLE TRIGGERING RECEPTOR ON MYELOID CELLS 1; STEROID; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE LUNG INJURY; ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; APACHE; BASIC RESEARCH; CHEMOPROPHYLAXIS; CLINICAL RESEARCH; CLOSTRIDIUM DIFFICILE INFECTION; COLLOID; COMMUNITY ACQUIRED PNEUMONIA; CRITICALLY ILL PATIENT; CRYSTALLOID; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ENDOTOXEMIA; EOSINOPENIA; EOSINOPHIL COUNT; FLUID THERAPY; GENETIC POLYMORPHISM; GENOMICS; GLYCEMIC CONTROL; HEMORRHAGIC SHOCK; HUMAN; HYPOGLYCEMIA; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERSTITIAL LUNG DISEASE; LOW DRUG DOSE; LUNG LAVAGE; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY (TOPIC); MULTIDRUG RESISTANCE; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; NONHUMAN; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; RESUSCITATION; REVIEW; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSGENIC MOUSE; TREATMENT OUTCOME; TUBERCULOSIS; VENTILATOR ASSOCIATED PNEUMONIA; MEDICAL RESEARCH;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CRITICAL CARE; HUMANS; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 77949897456     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7945     Document Type: Review

References (48)

1. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini J, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437.
2. El Solh AA, Akinnusi ME, Alsawalha L, Pineda L. Outcome of septic shock in older adults after implementation of the sepsis 'bundle'. J Am Geriatr Soc 2008, 56:272-278. 10.1111/j.1532-5415.2007.01529.x, 18047494.
3. Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J, Ibanez J, Palencia E, Quintana M, de la Torre-Prados MV. Improvement in process of care and outcome after a multicenter severe sepsis education program in Spain. JAMA 2008, 299:2294-2303. 10.1001/jama.299.19.2294, 18492971.
4. Carlet J, Cohen J, Calandra T, Opal SM, Masur H. Sepsis: time to reconsider the concept. Crit Care Med 2008, 36:964-966. 10.1097/CCM.0B013E318165B886, 18431286.
5. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Rheinhart K, Cutbertson BH, Payen D, Briegel J, . Corticus Study Group Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124. 10.1056/NEJMoa071366, 18184957, Corticus Study Group.
6. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871. 10.1001/jama.288.7.862, 12186604.
7. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grend S, Olthoff D, Jaschiniski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139. 10.1056/NEJMoa070716, 18184958.
8. The NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. 10.1056/NEJMoa0810625, 19318384, The NICE-SUGAR Study Investigators.
9. deSmet AMGA, Kluytmans JAJW, Cooper BS, Mascini EM, Benus RFJ, Werf TS, Hoeven JG, Pickkers P, Bogaers Hofman D, Meer NJM, Bernards AT, Kuijper EJ, Joore JCA, Leverstein-van Hall MA, Bindels AJGH, Jansz AR, Wesselink RMJ, de Jongh BM, Dennesen PJW, van Asselt GJ, te Velde LF, Frenay IHME, Kaasjager K, Bosch FH, van Iterson M, Thijsen SFT, Kluge GH, Pauw W, de Vries JW, Kaan JA, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009, 360:20-31. 10.1056/NEJMoa0800394, 19118302.
10. Huh JW, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Hong SB. Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care 2008, 12:R6. 2374623, 18205941, 10.1186/cc6770.
11. Abidi K, Khoudri I, Belayachi J, Mandani N, Zekraoui A, Zeggwagh AA, Abouqal R. Eosinopenia is a reliable marker of sepsis on admission to the medical intensive care units. Crit Care 2008, 12:R59. 2447615, 18435836, 10.1186/cc6883.
12. Wang H, Cheng B, Chen Q, Wu S, Lv S, Xie G, Jin Y, Fang X. Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care 2008, 12:R106. 2575595, 18706105, 10.1186/cc6988.
13. Nathani N, Perkins GD, Tunnicliffe W, Murphy N, Manji M, Thickett DR. Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome. Crit Care 2008, 12:R12. 2374609, 18269741, 10.1186/cc6785.
14. Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira, Paulo JZ. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 2008, 12:R11. 2374597, 18252006, 10.1186/cc6780.
15. Zhou M, Jacob A, Ho N, Miksa M, Wu R, Maitra SR, Wang P. Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release. Crit Care 2008, 12:R100. 2575589, 18680601, 10.1186/cc6977.
16. Weber S, Schewe JC, Lehmann LE, Muller S, Book M, Klaschik S, Hoeft A, Stuber F. Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care 2008, 12:R128. 2592767, 18925930, 10.1186/cc7088.
17. Trachsel S, Deby-Dupont G, Maurenbrecher E, Nys M, Lamy M, Hedenstierna G. Association between inflammatory mediators and response to inhaled nitric oxide in a model of endotoxin-induced lung injury. Crit Care 2008, 12:R131. 2592770, 18954441, 10.1186/cc7099.
18. Martins PS, Brunialti MKC, Martos LSW, Machado FR, Assuncao MS, Blecher S, Salomao R. Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit Care 2008, 12:R25. 2374621, 18302745, 10.1186/cc6801.
19. Li LF, Liao SK, Huang CC, Hung MJ, Quinn DA. Serine/threonine kinase-protein kinase B and extracellular signal-regulated kinase regulate ventilator-induced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment. Crit Care 2008, 12:R103. 2575592, 18691424, 10.1186/cc6983.
20. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350:451-458. 10.1056/NEJMoa031544, 14749453.
21. Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L, Buonsanti C, Colonna M, Sinigaglia F, Panina-Bordigon P, Fabbri LM. Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 2004, 24:247-250. 10.1183/09031936.04.00014204, 15332392.
22. Horonenko G, Hoyt JC, Robbins RA, Singarajah CU, Umar A, Pattengill J, Hayden JM. Soluble triggering receptor expressed on myeloid cells-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 2007, 132:58-63. 10.1378/chest.06-2731, 17505044.
23. Anand NJ, Zuick S, Klesney-Tait J, Kollef MH. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009, 135:641-647. 10.1378/chest.08-1829, 18849395.
24. Gil H, Magy N, Mauny F, Dupond JL. Value of eosinopenia in inflammatory disorders: an 'old' marker revisited. Rev Med Interne 2006, 27:431-435. 12829215.
25. Bass DA, Gonwa TA, Szejda P, Cousart S, DeChatelet LR, McCall CE. Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute infl ammation. J Clin Invest 1980, 65:1265-1271. 371463, 7410543, 10.1172/JCI109789.
26. Tang BMP, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217. 10.1016/S1473-3099(07)70052-X, 17317602.
27. Becker K, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008, 36:941-952. 10.1097/CCM.0B013E318165BABB, 18431284.
28. Lee WM, Galbraith RM. The extracellular actin-scavenging system and actin toxicity. N Engl J Med 1992, 326:1335-1341.
29. Osborn TM, Dahlgren C, Hartwig JH, Stossel TP. Modifications of the cellular responses to lypophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 2007, 292:C1323-C1330. 17135294, 10.1152/ajpcell.00510.2006.
30. Suhler E, Lin W, Yin HL, Lee WM. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock and myonecrosis. Crit Care Med 1997, 25:594-598. 10.1097/00003246-199704000-00007, 9142022.
31. Lee PS, Waxman AB, Cotich KL, Shung SW, Perrella MA, Stossel TP. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007, 35:849-855. 10.1097/01.CCM.0000253815.26311.24, 17205019.
32. Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB. Plasma gelsolin depletion and circulating actin in sepsis - a pilot study. PLoS One 2008, 3:e3712. 2577888, 19002257, 10.1371/journal.pone.0003712.
33. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006, 27:552-558. 17045842, 10.1016/j.it.2006.10.004.
34. Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008, 12:R147. 2646310, 19025590, 10.1186/cc7130.
35. Parikh SM, Mammoto T, Schultz A, Yuan H-T, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006, 3:e46. 1334221, 16417407, 10.1371/journal.pmed.0030046.
36. Witzenbichler B, Westermann D, Kneuppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005, 111:97-105. 10.1161/01.CIR.0000151287.08202.8E, 15611372.
37. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestuich GD, Macarenhas M, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medshitov R, Nobel PW. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005, 11:1173-1179. 10.1038/nm1315, 16244651.
38. Liu YY, Lee CH, Dedaj R, Zhao H, Mrabat H, Sheidlin A, Syrkina O, Huang PM, Garg HG, Hales CA, Quinn DA. High-molecular-weight hyaluronan - a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats. Crit Care 2008, 12:R102. 2575591, 18691420, 10.1186/cc6982.
39. Meulema DG. Orgaran (Org 10172): its pharmacological profile in experimental models. Haemostasis 1992, 22:58-65.
40. Bartlett AH, Hayashida K, Park PW. Molecular and cellular mechanisms of syndecans in tissue injury and inflammation. Mol Cells 2007, 24:153-166.
41. Iba T, Miyasho T. Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats. Crit Care 2008, 12:R86. 2575560, 18601748, 10.1186/cc6943.
42. Hagiwara S, Iwasaka H, Hidaka S, Hishiyama S, Noguchi T. Danaparoid sodium inhibits inflammation and prevents endotoxin-induced acute lung injury in rats. Crit Care 2008, 12:R43. 2447588, 18380908, 10.1186/cc6851.
43. Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D, Muñoz A. Unfractioned heparin for treatment of sepsis: a randomized clinical trial (the HETRASE Study). Crit Care Med 2009, 37:1185-1196. 10.1097/CCM.0b013e31819c06bc, 19242322.
44. Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A. Leukocyte apoptosis and its significance in sepsis and septic shock. J Leukoc Biol 2005, 78:325-337. 10.1189/jlb.0105017, 15817707.
45. Hostmann A, Jasse K, Schulze-Tanzil G, Robinson Y, Oberholzer A, Ertel W, Tschoeke SK. Biphasic onset of splenic apoptosis following hemorrhagic shock: critical implications for Bax, Bcl-2, and Mci-1 proteins. Crit Care 2008, 12:R8. 2374615, 18211685, 10.1186/cc6772.
46. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB-1: guiding immunity for within. Trends Immunol 2005, 26:381-387. 10.1016/j.it.2005.04.009, 15978523.
47. Kornblit B, Munthe-Fog L, Madsen HO, Strom J, Vindelov L, Garred P. Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care 2008, 12:R83. 2481482, 18577209, 10.1186/cc6935.
48. Flores C, del Mar Pino-Yanes M, Villar J. A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care 2008, 12:R130. 2592769, 18950526, 10.1186/cc7098.